As of 2026-04-04, the Relative Valuation of Balaxi Pharmaceuticals Ltd (BALAXI.NS) is 35.35 INR. This relative valuation is based on P/E multiples. With the latest stock price at 21.12 INR, the upside of Balaxi Pharmaceuticals Ltd based on Relative Valuation is 67.4%.
The range of the Relative Valuation is 19.04 - 51.90 INR.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 12.6x | 12.0x |
| Forward P/E multiples | 10.8x - 12.4x | 12.0x |
| Fair Price | 19.04 - 51.90 | 35.35 |
| Upside | -9.8% - 145.7% | 67.4% |
| Date | P/E |
| 2026-04-02 | 12.40 |
| 2026-04-01 | 11.04 |
| 2026-03-30 | 9.28 |
| 2026-03-27 | 9.97 |
| 2026-03-25 | 10.33 |
| 2026-03-24 | 10.60 |
| 2026-03-23 | 10.10 |
| 2026-03-20 | 10.40 |
| 2026-03-19 | 10.54 |
| 2026-03-18 | 10.45 |
| 2026-03-17 | 10.04 |
| 2026-03-16 | 10.16 |
| 2026-03-13 | 10.88 |
| 2026-03-12 | 12.26 |
| 2026-03-11 | 11.98 |
| 2026-03-10 | 11.98 |
| 2026-03-09 | 10.91 |
| 2026-03-06 | 11.51 |
| 2026-03-05 | 10.74 |
| 2026-03-04 | 10.57 |
| 2026-03-02 | 11.15 |
| 2026-02-27 | 11.59 |
| 2026-02-26 | 11.68 |
| 2026-02-25 | 12.15 |
| 2026-02-24 | 11.74 |
| 2026-02-23 | 11.85 |
| 2026-02-20 | 11.74 |
| 2026-02-19 | 11.98 |
| 2026-02-18 | 11.92 |
| 2026-02-17 | 12.22 |
| 2026-02-16 | 12.27 |
| 2026-02-13 | 12.68 |
| 2026-02-12 | 13.03 |
| 2026-02-11 | 12.92 |
| 2026-02-10 | 13.17 |
| 2026-02-09 | 13.44 |
| 2026-02-06 | 13.44 |
| 2026-02-05 | 13.49 |
| 2026-02-04 | 14.09 |
| 2026-02-03 | 15.07 |
| 2026-02-02 | 14.09 |
| 2026-02-01 | 14.56 |
| 2026-01-30 | 14.09 |
| 2026-01-29 | 14.15 |
| 2026-01-28 | 14.69 |
| 2026-01-27 | 14.41 |
| 2026-01-23 | 14.28 |
| 2026-01-22 | 15.14 |
| 2026-01-21 | 13.57 |
| 2026-01-20 | 14.05 |